Skip to main content

Moderna COVID-19 vaccine may pose higher heart inflammation risk: CDC

Share

Moderna's COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech's shot, the U.S. Centers for Disease Control and Prevention said on Tuesday, citing recent data.

The agency, however, said the findings on myocarditis and pericarditis, types of heart inflammation linked to both the mRNA shots, were not consistent across all of the U.S. vaccine safety monitoring systems.

The CDC's analysis comes as the U.S. Food and Drug Administration's advisers meet on Tuesday to discuss the authorization of Moderna's vaccine for children and teens aged 6-17.

Based on data from the Vaccine Safety Datalink (VSD) system, the incidence of heart inflammation was 97.3 cases per million doses for males aged 18-39 following a second dose of Moderna's shot, versus 81.7 cases per million Pfizer vaccine doses.

Available information suggests that most people with myocarditis after mRNA COVID-19 vaccination recover over time, the CDC said.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty and Anil D'Silva

CTVNews.ca Top Stories

MPs targeted by Chinese hackers question why Canada didn't tell them

Members of Parliament are questioning why Canadian security officials did not inform them that they had been the target of Beijing-linked hackers, after learning from the FBI that the international parliamentary alliance they are a part of was in the crosshairs of the Chinese cyberattack in 2021.

WATCH

WATCH So you haven't filed your taxes yet…

The clock is ticking ahead of the deadline to file a 2024 income tax return. A personal finance expert explains why you should get them done -- even if you owe more than you can pay.

Local Spotlight

Stay Connected